Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,436 | -65,772 | -52,121 | -35,866 | -17,221 |
| Depreciation Amortization | 1,029 | 4,213 | 2,688 | 1,705 | 824 |
| Accounts receivable | -5,971 | -7,536 | -2,484 | 466 | -5,717 |
| Accounts payable and accrued liabilities | -1,205 | 3,008 | 2,500 | 180 | -1,313 |
| Other Working Capital | -53 | 2,759 | 6,458 | 7,990 | -2,565 |
| Other Operating Activity | 7,932 | 10,067 | 4,767 | 3,270 | 10,053 |
| Operating Cash Flow | $-12,704 | $-53,261 | $-38,192 | $-22,255 | $-15,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,042 | -2,897 | -7,560 | -5,800 | 4,863 |
| PPE Investments | -286 | -2,497 | -2,096 | -1,776 | -198 |
| Purchase Sale Intangibles | -17 | -361 | -68 | -49 | 0 |
| Other Investing Activity | -17 | 2,861 | 3,154 | 3,173 | 481 |
| Investing Cash Flow | $5,739 | $-2,533 | $-6,502 | $-4,403 | $5,146 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -227 | -989 | -784 | -379 | -163 |
| Common Stock Issued | N/A | 64,560 | 64,564 | 60,087 | 30,265 |
| Common Stock Repurchased | N/A | -120 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -40 | -40 | -40 | 0 |
| Financing Cash Flow | $-227 | $63,411 | $63,740 | $59,668 | $30,102 |
| Beginning Cash Position | 31,969 | 24,352 | 24,352 | 24,352 | 24,352 |
| End Cash Position | 24,777 | 31,969 | 43,398 | 57,362 | 43,661 |
| Net Cash Flow | $-7,192 | $7,617 | $19,046 | $33,010 | $19,309 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,704 | -53,261 | -38,192 | -22,255 | -15,939 |
| Capital Expenditure | -286 | -2,497 | -2,096 | -1,776 | -198 |
| Free Cash Flow | -12,990 | -55,758 | -40,288 | -24,031 | -16,137 |